The CaMKIIa promoter targets viral infection to glutamatergic neurons within the injected brain regions (see Methods), and we confirmed that optically induced currents are blocked completely by glutamate receptor antagonists (Supplementary Fig. 2c). This evidence concerns the gene CAMK2A and viral infectious disease.